Tiber Creek Health Strategies, INC. (on Behalf of Genentech, INC.)
Government relations.
Based in DC
🤖
AI Overview
With $1.4M in lobbying spend across 32 quarterly filings, Tiber Creek Health Strategies, INC. (on Behalf of Genentech, INC.) is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
$1.4M
Total Spend
8
Years Active
1
Firms Hired
2
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $40K |
| 2019 | $80K |
| 2020 | $80K |
| 2021 | $200K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Copyright/Patent, Trade
- •Issues related to the Public Health Service Act-340b pricing.
- •Issues related to the Public Health Service Act-340b pricing. Issues related to the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018, S.2852.
- •Issues related to the Public Health Service Act (Public Law 78-410); 340b pricing.
- •Issues relating to Part B pricing reform
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
Similar Clients
GSK (FKA Glaxosmithkline INC.)
$39.9M total spend
Siemens Healthineers (FKA Varian Medical Systems, INC.)
$1.9M total spend
Association for Accessible Medicines (Formerly - Generic Pharmaceutical Assn)
$1.3M total spend
Campaign for Sustainable Drug Pricing
$580K total spend
Bayer Corporation (Consolidated Report)
$73.0M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.